Primo Chemicals Board Approves Q2 & Half-Year Results; H1 Profit Soars Despite Q2 Dip
Primo Chemicals announced Q2 and H1 FY26 results. While Q2 profits significantly dipped year-on-year, half-year profits showed substantial growth, with revenues also increasing.
The impact is medium as financial results are always important, but the mixed performance, with strong half-year profit growth contrasted by a significant quarterly profit decline, might lead to a tempered market reaction.
The sentiment is neutral because, while the half-year profit after tax showed substantial growth (standalone up 274%, consolidated up 391%), the profit for the quarter ended 30 September 2025 significantly declined compared to the same quarter last year (standalone down 79%, consolidated down 68%), despite stable revenue.
* Primo Chemicals Limited's Board of Directors, in a meeting held on 14 November 2025, approved the unaudited standalone and consolidated financial results for the quarter and half-year ended 30 September 2025. * For the quarter ended 30 September 2025, standalone revenue from operations was ₹13474.48 lakhs, while profit after tax stood at ₹275.33 lakhs. This represents a significant decrease in profit compared to ₹1326.38 lakhs in the same quarter of the previous year (30 September 2024), despite revenue remaining stable. * Consolidated revenue from operations for the quarter was ₹13474.48 lakhs, with net profit after associates at ₹416.38 lakhs, a notable decline from ₹1292.77 lakhs reported in the corresponding quarter last year. * For the half-year ended 30 September 2025, standalone revenue from operations increased to ₹27668.86 lakhs from ₹25629.02 lakhs in the previous half-year. Standalone profit after tax surged to ₹580.88 lakhs, a substantial increase from ₹155.28 lakhs in the half-year ended 30 September 2024. * Consolidated revenue for the half-year ended 30 September 2025 rose to ₹27668.86 lakhs. Consolidated net profit after associates dramatically increased to ₹824.14 lakhs from ₹167.80 lakhs in the previous half-year. * The company operates in a single business segment: Chemicals. * Primo Chemicals Limited holds 49% equity in M/s. FlowTech Chemicals (P) Limited, treated as an Associate Concern. * Investor complaints for the quarter ended 30 September 2025 remained Nil, with no pending, received, or unresolved complaints.
What to do with a filing like this
Primo Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Primo Chemicals Limited. Read the original for the full detail.